J. C. Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
J. C. Chen has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Samilia Obeng-Gyasi
Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH
27 shared publications - Jesse J. Plascak
Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
20 shared publications - Mohamed I. Elsaid
Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH
20 shared publications - Demond Handley
The Ohio State University
19 shared publications - Jesus D. Anampa
Department of Medical Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York
18 shared publications - Timothy Michael Pawlik
Department of Surgery The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center Columbus Ohio USA
4 shared publications
Latest Publications
- Open Access
- 9 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0342984
Factors correlated with financial hardship among cancer patients during the COVID-19 pandemic
Purpose: Financial hardship from cancer care is associated with poor patient outcomes. Economic disruption during the COVID-19 pandemic may have exacerbated patients’ financial concerns. We explore how social deprivation index (SDI), clinical, and treatment-related factors impacted financial hardship in this observational secondary analysis using data collected prospectively during implementation of financial hardship screening from our NCI-designated center during COVID-19. Methods: Adults aged ≥18 years undergoing active treatment for stage 0-IV breast or lung cancer and who completed a 5-point Likert response-item screening for financial difficulty between 11/2020 and 11/2021 were included. Generalized estimating equations assessed associations between quartiles of zip-code level SDI, a composite obtained using data from US Census and American Community Survey, and binary outcome of financial hardship adjusting for relevant covariates . Results: Of 2245 patients, 87% identified as White, 9% as Black, 2% as Asian. The majority of patients identified as non-Hispanic (99%). Median age was 62 years old (IQR 53–71).The majority were treated for breast cancer (79%). Significant financial hardship (Likert responses ≥2) was reported by 7%. Most were married, had managed-care insurance, resided in urban settings, and had early-stage cancers (all p < 0.001). Of those included, 83% received surgery, 52% received chemotherapy, and 65% received radiation. Compared to the lowest SDI quartile, penultimate and highest quartiles were associated with financial hardship (Q3 aOR 1.86; 95%CI 1.13–3.05); Q4 aOR 2.05; 95%CI 1.15–3.63). Younger age, Black race, comorbidities, radiation, and chemotherapy were also associated with greater financial hardship (p < 0.05). Conclusion: In this study, greater SDI, younger age, Black race, comorbidities, receipt of radiation and/or chemotherapy were associated with financial hardship. These factors may guide focused screening of vulnerable populations to assist with equitable access to resources that offset the economic effects of cancer care.
- 9 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0342984
Open AccessFactors correlated with financial hardship among cancer patients during the COVID-19 pandemic
Purpose: Financial hardship from cancer care is associated with poor patient outcomes. Economic disruption during the COVID-19 pandemic may have exacerbated patients’ financial concerns. We explore how social deprivation index (SDI), clinical, and treatment-related factors impacted financial hardship in this observational secondary analysis using data collected prospectively during implementation of financial hardship screening from our NCI-designated center during COVID-19. Methods: Adults aged ≥18 years undergoing active treatment for stage 0-IV breast or lung cancer and who completed a 5-point Likert response-item screening for financial difficulty between 11/2020 and 11/2021 were included. Generalized estimating equations assessed associations between quartiles of zip-code level SDI, a composite obtained using data from US Census and American Community Survey, and binary outcome of financial hardship adjusting for relevant covariates . Results: Of 2245 patients, 87% identified as White, 9% as Black, 2% as Asian. The majority of patients identified as non-Hispanic (99%). Median age was 62 years old (IQR 53–71).The majority were treated for breast cancer (79%). Significant financial hardship (Likert responses ≥2) was reported by 7%. Most were married, had managed-care insurance, resided in urban settings, and had early-stage cancers (all p < 0.001). Of those included, 83% received surgery, 52% received chemotherapy, and 65% received radiation. Compared to the lowest SDI quartile, penultimate and highest quartiles were associated with financial hardship (Q3 aOR 1.86; 95%CI 1.13–3.05); Q4 aOR 2.05; 95%CI 1.15–3.63). Younger age, Black race, comorbidities, radiation, and chemotherapy were also associated with greater financial hardship (p < 0.05). Conclusion: In this study, greater SDI, younger age, Black race, comorbidities, receipt of radiation and/or chemotherapy were associated with financial hardship. These factors may guide focused screening of vulnerable populations to assist with equitable access to resources that offset the economic effects of cancer care.
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 3 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplemental Table 5 evaluates a dose response of healthcare utilization characterized by racial and economic residential segregation percentiles
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplemental Table 5 evaluates a dose response of healthcare utilization characterized by racial and economic residential segregation percentiles
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 1 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 11 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Table 11 shows a preliminary causal mediation analysis examining the association between ICE-race-income and healthcare utilization
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 11 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Table 11 shows a preliminary causal mediation analysis examining the association between ICE-race-income and healthcare utilization
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 2 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Results from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
These are results from the supplementary analysis and slo includes the supplementary figure legends
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Results from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
These are results from the supplementary analysis and slo includes the supplementary figure legends
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Data from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Background:Racialized economic segregation is linked to higher cancer-specific mortality; however, its impact on healthcare utilization (HCU) remains unclear. This study used the metric Index of Concentration at the Extremes (ICE) and evaluated the association between racial residential segregation (ICErace), racialized economic segregation (ICErace + income), and HCU among patients with breast cancer receiving chemotherapy.Methods:Patients ≥18 years who received chemotherapy and surgical management for stage I to III breast cancer (2012–2020) were identified in the electronic health record. Census tract–level ICErace and ICErace + income were derived from the 2008 to 2012 American Community Survey. HCU was defined as hospitalizations or emergency room visits during chemotherapy. General estimating equations with robust variance estimated associations between segregation indices and HCU. Mediation analyses examined the effect of ICErace + income on HCU.Results:Among 2,037 women (mean age, 53.7 ± 11.9 years), 10.6% were Black, 84.6% were White, and 4.8% were other. Higher concentrations of White residents were associated with reduced HCU risk [ICErace fifth quintile; risk ratio (RR) = 0.44; 95% confidence interval (CI), 0.32–0.59; reference: first quintile). A significant interaction was observed between ICErace and race (P = 0.009). The relationship between ICErace + income and HCU was nonlinear: HCU risk decreased progressively from the fifth percentile (RR = 0.97; 95% CI, 0.92–0.99) to the 63rd percentile (RR = 0.69; 95% CI, 0.49–0.99). Most of the ICErace + income effect on HCU was direct (OR = 0.88; 95% CI, 0.83–0.93), with minimal mediation by comorbidities (2.0%).Conclusions:Residence in racially and economically segregated census tracts is associated with greater HCU.Impact:These findings highlight structural racism as a determinant of cancer treatment burden, emphasizing the importance of neighborhood context in disparities and care delivery.
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Background:Racialized economic segregation is linked to higher cancer-specific mortality; however, its impact on healthcare utilization (HCU) remains unclear. This study used the metric Index of Concentration at the Extremes (ICE) and evaluated the association between racial residential segregation (ICErace), racialized economic segregation (ICErace + income), and HCU among patients with breast cancer receiving chemotherapy.Methods:Patients ≥18 years who received chemotherapy and surgical management for stage I to III breast cancer (2012–2020) were identified in the electronic health record. Census tract–level ICErace and ICErace + income were derived from the 2008 to 2012 American Community Survey. HCU was defined as hospitalizations or emergency room visits during chemotherapy. General estimating equations with robust variance estimated associations between segregation indices and HCU. Mediation analyses examined the effect of ICErace + income on HCU.Results:Among 2,037 women (mean age, 53.7 ± 11.9 years), 10.6% were Black, 84.6% were White, and 4.8% were other. Higher concentrations of White residents were associated with reduced HCU risk [ICErace fifth quintile; risk ratio (RR) = 0.44; 95% confidence interval (CI), 0.32–0.59; reference: first quintile). A significant interaction was observed between ICErace and race (P = 0.009). The relationship between ICErace + income and HCU was nonlinear: HCU risk decreased progressively from the fifth percentile (RR = 0.97; 95% CI, 0.92–0.99) to the 63rd percentile (RR = 0.69; 95% CI, 0.49–0.99). Most of the ICErace + income effect on HCU was direct (OR = 0.88; 95% CI, 0.83–0.93), with minimal mediation by comorbidities (2.0%).Conclusions:Residence in racially and economically segregated census tracts is associated with greater HCU.Impact:These findings highlight structural racism as a determinant of cancer treatment burden, emphasizing the importance of neighborhood context in disparities and care delivery.
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Table 10 shows a causal mediation analysis examining the effect of ICE-race-income on healthcare utilization
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Table 10 shows a causal mediation analysis examining the effect of ICE-race-income on healthcare utilization
- Open Access
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 4 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
- 9 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy
Supplementary Figure 4 from Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy